开发和初步测试基于人工智能的虚拟现实伴侣,用于长期护理中患有痴呆症的人
Lisa Sheehy1, Stéphane Bouchard2, Anupriya Kakkar1
1Bruyère Research Institute, 43 Bruyère St., Ottawa, ON K1N 5C8, Canada.
Journal of clinical medicine
|September 28, 2024
概括
一个使用虚拟现实和人工智能的虚拟伴侣是为长期护理中痴呆症患者开发的. 虽然最初的版本有局限性,但以后的AI增强版本促进了有意义的对话,显示了减少孤独的希望.
科学领域:
- 老年学是指老年学的学科.
- 人与计算机的交互
- 人工智能的人工智能
背景情况:
- 孤独是长期护理 (LTC) 中痴呆症 (PLWD) 患者的一个重要问题.
- 虚拟伴侣提供了一个潜在的解决方案,以解决这一群体的社会隔离问题.
研究的目的:
- 在LTC中为PLWD开发一个新的虚拟伴侣.
- 评估这个虚拟伴侣技术的可行性和可接受性.
主要方法:
- 一个虚拟伴侣是在两个阶段开发的,利用虚拟现实和人工智能.
- 在LTC的PLWD测试了该应用程序,在每个阶段都提供了关于可行性和可接受性的反.
主要成果:
- 第1阶段表现出语音识别和对话范围的局限性,影响了接受.
- 第二阶段,增强了人工智能,促进了亲密和有意义的对话,尽管一些用户发现头戴式耳机很重.
- 这项技术对能够进行相互对话的PLWD最有效; 响应延迟被认为是未来的改进.
结论:
- 虚拟现实和人工智能可以在LTC中为一些PLWD创建可接受和愉快的虚拟伴侣.
- 未来的代可以通过硬件和软件的进步来改善对话互动和社交体验.
相关概念视频
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Cognitive Development During Adulthood
65
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
65
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Continuing Care
1.4K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.4K
Dementia
99
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
99
Documentation in Long-Term and Home Healthcare Setting
873
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
873


